DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02348 DAWNRAYS PHARMA

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Li Kei Ling & Associates (47.21%)
Leung Hong Man & Associates (7.47%)
??????????? (7.24%)
Li Tung Ming (5.34%)		 Sector Health Care & Biotechnology
Web Site http://www.dawnrays.com Tel (852) 2111-9708
Email ir@dawnrays.com.hk Fax (852) 2111-9870
Related Equities N/A
Principal Activities Principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines including intermediate pharmaceutical, bulk medicines and finished drugs.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top